PTC Therapeutics sees several potential catalysts in 2025
Source: SeekingAlpha
2025-01-13 12:11:21 ET
More on PTC Therapeutics
- PTC Therapeutics: ALS Drug Fail Kicks Off Critical Year Of Catalysts
- PTC Therapeutics, Inc. (PTCT) Q3 2024 Earnings Call Transcript
- PTC Therapeutics submits NDA for Friedreich ataxia treatment vatiquinone
- Morgan Stanley upgrades PTC, cuts Immuneering, Amicus
- Seeking Alpha’s Quant Rating on PTC Therapeutics
Read the full article on Seeking Alpha
For further details see:
PTC Therapeutics sees several potential catalysts in 2025
Champion Industries Inc
NASDAQ: CHMP
CHMP Trading
19900.0% G/L:
$0.02 Last:
342 Volume:
$0.02 Open:
CHMP Latest News
CHMP Stock Data
$7,319
24,723
21.8%
1
43%
Industrial Goods
Industrials
US
Huntington
